<doc><docmeta id="113hr315ih">
    <bill congress="113" type="hr" number="315" version="ih"/>
    <revision id="5" commit-time="2013-03-11T04:17:04+00:00" comitter="/users/favila.xml" doc="/docs/113hr315ih/5.xml" status="complete"><description/></revision>
</docmeta><bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H24EA6B0C056E403FA4CF225B4A168B59" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 315</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130118">January 18, 2013</action-date>
			<action-desc>
        <sponsor name-id="E000172">Mrs. Emerson</sponsor>
			 introduced the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>, and in addition to the Committee on the
			 <committee-name committee-id="HJU00">Judiciary</committee-name>, for a period
			 to be subsequently determined by the Speaker, in each case for consideration of
			 such provisions as fall within the jurisdiction of the committee
			 concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To provide for the placement of certain synthetic drugs
		  on Schedule I under the Controlled Substances Act.</official-title>
	</form>
	<legis-body id="H03AA638B9DA54FCB92F8AA896EC26D45" style="OLC">
		<section id="H48D1452207F34C93BD68692D738827CF" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Synthetic Cathinones Control Act of
			 2013</short-title>
        </quote>.</text>
		</section>
    <section id="H13644DE0FF5C4766860A6B2F57A41DAA">
      <enum>2.</enum>
      <header>Addition of
			 synthetic drugs to Schedule I of the Controlled Substances Act</header>
			<subsection id="HB3BA0DD3253248A78CF45F6CED0079EF">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text display-inline="yes-display-inline">Notwithstanding any
			 other provision of the <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act">Controlled Substances Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/801/etseq">21 U.S.C. 801 et seq.</cato:entity-ref>)</cato:entity>, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref> shall, not later than 60 days after the date of the enactment
			 of this Act, issue a final order that schedules the following substances on
			 schedule I under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:202/ss:c">section 202(c) of that Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/812/c">21 U.S.C. 812(c)</cato:entity-ref>)</cato:entity>:</text>
				<paragraph id="H6D2ED50B6BC44E79A062DF5D06B1CAA8">
          <enum>(1)</enum>
          <text>3,4-methylenedioxymethcathinone
			 (meth­yl­one).</text>
				</paragraph>
        <paragraph id="H9939D31E245945F8980B7E56031FD071">
          <enum>(2)</enum>
          <text>Naphthylpyrovalerone
			 (naphyrone).</text>
				</paragraph>
        <paragraph id="H5E73FE82D8EC4F2BB0756D8B169FB6A6">
          <enum>(3)</enum>
          <text>4-fluoromethcathinone
			 (flephedrone).</text>
				</paragraph>
        <paragraph id="HF3BD93C29BA74C709CD84197CB52A557">
          <enum>(4)</enum>
          <text>4-methoxymethcathinone
			 (methedrone; Bk–PMMA).</text>
				</paragraph>
        <paragraph id="HB743709D222245A99223C6419E0FDCDD">
          <enum>(5)</enum>
          <text>Ethcathinone
			 (N-ethylcathinone).</text>
				</paragraph>
        <paragraph id="H0AB304350A8846929035E9E618260BEC">
          <enum>(6)</enum>
          <text>3,4-methylenedioxyethcathinone
			 (ethylone).</text>
				</paragraph>
        <paragraph id="H1944B39FD5464F49AB15CE94363E28E0">
          <enum>(7)</enum>
          <text>Beta-keto-N-methyl-3,4-benzo­di­oxy­oly­bu­tan­amine
			 (butylone).</text>
				</paragraph>
        <paragraph id="HAB5CE302178240D3A91C409FD68ABEF4">
          <enum>(8)</enum>
          <text>N,N-dimethylcathinone
			 (metamfepramone).</text>
				</paragraph>
        <paragraph id="H33A40F2C87EB4C29ADF800FE8385983A">
          <enum>(9)</enum>
          <text>Alpha-pyrrolidinopropiophenone
			 (alpha-PPP).</text>
				</paragraph>
        <paragraph id="H13E296052ECC4CF6B6B4DD424A53FF60">
          <enum>(10)</enum>
          <text>4-methoxy-alphapyrrolidinopropiophenone
			 (MOPPP).</text>
				</paragraph>
        <paragraph id="H462EF5D208C4435E95DB4ADC7FFECFD9">
          <enum>(11)</enum>
          <text>3,4-meth­yl­ene­di­oxy­alpha­pyrrol­idino­pro­pio­phe­none
			 (MDPPP).</text>
				</paragraph>
        <paragraph id="HBD3BE3B4271640B1ADBC5F0891C78CD6">
          <enum>(12)</enum>
          <text>Alpha-pyrrolidinovalerophenone
			 (alpha-PVP).</text>
				</paragraph>
        <paragraph id="H253042C7A50F4A998516A62791CFAF6E">
          <enum>(13)</enum>
          <text>6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine
			 (MDAI).</text>
				</paragraph>
        <paragraph id="H1727BA5E257A4A9C922E79797990D2AA">
          <enum>(14)</enum>
          <text>3-fluoromethcathinone.</text>
				</paragraph>
        <paragraph id="H04BFECC308BD43EFA5140B80F47979B5">
          <enum>(15)</enum>
          <text>4′-methyl-α-pyrrolidinobutiophenone
			 (MPBP).</text>
				</paragraph>
      </subsection>
      <subsection id="H4638A5FC4DEC47369187737EC4528195">
        <enum>(b)</enum>
        <header>Conforming
			 amendment To remove deadwood</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:202/ss:c">Subsection (c) of section 202 of the
			 Controlled Substances Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/802">21 U.S.C. 802</cato:entity-ref>)</cato:entity> is amended to read as follows:</text>
				<quoted-block display-inline="no-display-inline" id="HDB9F38D632C341D78ACC48B5E41ADC04" style="OLC">
					<subsection id="H6D686D9DB1F8486B8E095E91A79B71FC">
            <enum>(c)</enum>
            <header>Cross reference
				to Schedules of Controlled Substances</header>
            <text display-inline="yes-display-inline">Schedules I, II, III, IV, and V shall
				consist of the drugs and other substances (by whatever official name, common or
				usual name, chemical name, or brand name designated) that are set forth in the
				respective schedules in part 1308 of title 21, Code of Federal Regulations, as
				they may be amended from time to time, or in any successor
				regulation.</text>
					</subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
    </section>
  </legis-body>
</bill></doc>